Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2014

01.11.2014 | Maternal-Fetal Medicine

Calcitonin gene- and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case–control study

verfasst von: Sonali Yadav, Yogendra Singh Yadav, Madhu Mati Goel, Urmila Singh, Shankar Madhav Natu, Mahendra Pal Singh Negi

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify whether CGRP and PTHrP serve as screening biomarkers for early detection of preeclampsia or even before the development of preeclampsia in early pregnancy.

Methods

It was a nested case–control study. The subjects were divided into normotensive (controls) and preeclamptic (cases) groups. Serum samples of 132 cases and 132 controls were collected during pregnancy at three different gestational periods and one sample post delivery, from within the cohort of pregnant women reporting to antenatal clinic. Circulating levels of CGRP and PTHrP were analyzed by enzyme-linked immunosorbent assay.

Results

Maternal serum concentrations of CGRP and PTHrP increased with the advancement of gestation age in both normotensive and preeclamptic pregnancies but the significantly less increased levels were observed in preeclamptic pregnancies as compared with normotensive pregnancies. In postpartum period level of CGRP significantly falls in both groups although level of PTHrP continues to increase even after delivery. Maternal serum CGRP and PTHrP concentrations were positively correlated with the infant’s birth weights.

Conclusion

Maternal circulating CGRP and PTHrP concentrations were significantly lower in women with preeclampsia, which may contribute to the development of preeclampsia.
Literatur
1.
Zurück zum Zitat Duvekott JJ, Cheriex EC, Pieters FAA et al (1993) Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a fall in systemic vascular tone. Am J Obstet Gynecol 169:1382–1392CrossRef Duvekott JJ, Cheriex EC, Pieters FAA et al (1993) Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a fall in systemic vascular tone. Am J Obstet Gynecol 169:1382–1392CrossRef
2.
Zurück zum Zitat Robertson WB, Brosens I, Dixon HG (1967) The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 93:581–592PubMedCrossRef Robertson WB, Brosens I, Dixon HG (1967) The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 93:581–592PubMedCrossRef
3.
Zurück zum Zitat Gerretsen G, Huisjes HJ, Elema JD (1981) Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 88:876–881PubMedCrossRef Gerretsen G, Huisjes HJ, Elema JD (1981) Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 88:876–881PubMedCrossRef
4.
Zurück zum Zitat World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy (1988) Geographic variation in the incidence of hypertension in pregnancy. Am J Obst Gynecol 158:80–83CrossRef World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy (1988) Geographic variation in the incidence of hypertension in pregnancy. Am J Obst Gynecol 158:80–83CrossRef
5.
Zurück zum Zitat WHO (2005) Make every mother and child count, in the world health report 2005. World Health Organization, Geneva WHO (2005) Make every mother and child count, in the world health report 2005. World Health Organization, Geneva
7.
8.
Zurück zum Zitat Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of preeclampsia. Annu Rev Pathol 5:173–192PubMedCrossRef Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of preeclampsia. Annu Rev Pathol 5:173–192PubMedCrossRef
9.
Zurück zum Zitat Baviera G, D’Anna R, Corrado F, Ruello A, Buemi M, Jasonni VM (2002) ICAM-1 in maternal plasma and amniotic fluid as an early marker of pre-eclampsia and IUGR. J Reprod Med 47(3):191–193PubMed Baviera G, D’Anna R, Corrado F, Ruello A, Buemi M, Jasonni VM (2002) ICAM-1 in maternal plasma and amniotic fluid as an early marker of pre-eclampsia and IUGR. J Reprod Med 47(3):191–193PubMed
10.
Zurück zum Zitat Bell D, McDermott BJ (1996) Calcitonin gene-related peptide in the cardio-vascular system: characterization of receptor populations and their pathophysiological significance. Pharmacol Rev 48:253–288PubMed Bell D, McDermott BJ (1996) Calcitonin gene-related peptide in the cardio-vascular system: characterization of receptor populations and their pathophysiological significance. Pharmacol Rev 48:253–288PubMed
11.
Zurück zum Zitat Wimalawansa SJ (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17:533–585PubMedCrossRef Wimalawansa SJ (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17:533–585PubMedCrossRef
12.
Zurück zum Zitat DiPette DJ, Wimalawansa SJ (1995) Calcium regulating hormones and cardio-vascular function. In: Cross JI, Aveoli LV (eds) Cardiovascular actions of calcitropic hormones. CRC, Baltimore, pp 239–252 DiPette DJ, Wimalawansa SJ (1995) Calcium regulating hormones and cardio-vascular function. In: Cross JI, Aveoli LV (eds) Cardiovascular actions of calcitropic hormones. CRC, Baltimore, pp 239–252
13.
Zurück zum Zitat Asimakis GK, DiPette DJ, Conti VR, Holland OB, Zwischenberger JB (1987) Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart. Life Sci 41:597–603PubMedCrossRef Asimakis GK, DiPette DJ, Conti VR, Holland OB, Zwischenberger JB (1987) Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart. Life Sci 41:597–603PubMedCrossRef
14.
Zurück zum Zitat Yallampalli C, Dong YL, Wimalawansa SJ (1996) Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in preeclampsia rats induced by NG-nitro-l-arginine methyl ester. Hum Reprod 11(4):895–899CrossRef Yallampalli C, Dong YL, Wimalawansa SJ (1996) Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in preeclampsia rats induced by NG-nitro-l-arginine methyl ester. Hum Reprod 11(4):895–899CrossRef
15.
Zurück zum Zitat Gude NM, King RG, Brennecke SP (1996) Factors regulating placenta hemodynamics. In: Sastry BVR (ed) Placental pharmacology. CRC, Boca Raton, pp 23–45 Gude NM, King RG, Brennecke SP (1996) Factors regulating placenta hemodynamics. In: Sastry BVR (ed) Placental pharmacology. CRC, Boca Raton, pp 23–45
16.
Zurück zum Zitat Maggi CA, Meli A (1988) The sensor-efferent function of capsaicin-sensitive neurons. Gen Pharmacol 19(1):1–43PubMedCrossRef Maggi CA, Meli A (1988) The sensor-efferent function of capsaicin-sensitive neurons. Gen Pharmacol 19(1):1–43PubMedCrossRef
17.
Zurück zum Zitat Roberts JM (2000) Preeclampsia: what we know and what we do not know. Semin Perinatol 24:24–28PubMedCrossRef Roberts JM (2000) Preeclampsia: what we know and what we do not know. Semin Perinatol 24:24–28PubMedCrossRef
18.
Zurück zum Zitat Brosens JJ, Pijnenborg R, Brosens IA (2002) The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187:1416–1423PubMedCrossRef Brosens JJ, Pijnenborg R, Brosens IA (2002) The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187:1416–1423PubMedCrossRef
19.
Zurück zum Zitat Robertson WB, Brosens I, Dixon G (1976) Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens 5:115–127PubMed Robertson WB, Brosens I, Dixon G (1976) Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens 5:115–127PubMed
20.
Zurück zum Zitat Zhou Y, Fisher SJ, Janatpour M et al (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99:2139–2151PubMedCrossRefPubMedCentral Zhou Y, Fisher SJ, Janatpour M et al (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99:2139–2151PubMedCrossRefPubMedCentral
21.
22.
Zurück zum Zitat Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med 350:672–683PubMedCrossRef Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med 350:672–683PubMedCrossRef
23.
Zurück zum Zitat Fisher SJ, Roberts JM (1999) Defects in placentation and placental perfusion. In: Lindheimer MD, Roberts JM, Cunningham FG (eds) Chelsey’s hypertensive disorders in pregnancy, 2nd edn. Appleton and Lange, pp 377–394 Fisher SJ, Roberts JM (1999) Defects in placentation and placental perfusion. In: Lindheimer MD, Roberts JM, Cunningham FG (eds) Chelsey’s hypertensive disorders in pregnancy, 2nd edn. Appleton and Lange, pp 377–394
24.
Zurück zum Zitat Rinehart BK et al (1999) Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 181:915–920PubMedCrossRef Rinehart BK et al (1999) Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 181:915–920PubMedCrossRef
25.
Zurück zum Zitat Roberts JM, Taylor RN, Goldfien A (1991) Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4:700–708PubMed Roberts JM, Taylor RN, Goldfien A (1991) Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4:700–708PubMed
26.
Zurück zum Zitat Chen Yu (2009) Novel angiogenic factors for predicting preeclampsia: sFlt-1, PlGF, and soluble endoglin. Open Clin Chem J 2:1–6CrossRef Chen Yu (2009) Novel angiogenic factors for predicting preeclampsia: sFlt-1, PlGF, and soluble endoglin. Open Clin Chem J 2:1–6CrossRef
27.
Zurück zum Zitat Seely EW, Wood RJ, Brown EM, Graves SW (1992) Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab 74:1436–1440PubMed Seely EW, Wood RJ, Brown EM, Graves SW (1992) Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab 74:1436–1440PubMed
28.
Zurück zum Zitat Halhali A, Tovar AR, Torres N, Bourges H, Garabe´dian M, Larrea F (2000) Preeclampsia is associated with low circulating levels of insulin like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 85:1828–1833PubMed Halhali A, Tovar AR, Torres N, Bourges H, Garabe´dian M, Larrea F (2000) Preeclampsia is associated with low circulating levels of insulin like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 85:1828–1833PubMed
29.
Zurück zum Zitat Wimalawansa SJ (1993) Antihypertensive effects of oral calcium supplementation is mediated through the potent vasodilator CGRP. Am J Hypertens 6:996–1002PubMed Wimalawansa SJ (1993) Antihypertensive effects of oral calcium supplementation is mediated through the potent vasodilator CGRP. Am J Hypertens 6:996–1002PubMed
30.
Zurück zum Zitat Wimalawansa SJ, Supowit SC, DiPette DJ (1995) Mechanisms of the antihypertensive effects of dietary calcium and role of calcitonin gene-related peptide in hypertension. Can J Physiol Pharmacol 73:981–985PubMedCrossRef Wimalawansa SJ, Supowit SC, DiPette DJ (1995) Mechanisms of the antihypertensive effects of dietary calcium and role of calcitonin gene-related peptide in hypertension. Can J Physiol Pharmacol 73:981–985PubMedCrossRef
31.
Zurück zum Zitat Wysolmerski JJ, Stewart AF (1998) The physiology of parathyroid hormone-related protein: an emerging role as a developmental factor. Annu Rev Physiol 60:431–460PubMedCrossRef Wysolmerski JJ, Stewart AF (1998) The physiology of parathyroid hormone-related protein: an emerging role as a developmental factor. Annu Rev Physiol 60:431–460PubMedCrossRef
32.
Zurück zum Zitat Ariza AC, Bobadilla N, Diaz L, Avila E, Larrea F, Halhali A (2009) Placental gene expression of calcitonin gene related peptide and nitric oxide synthases in preeclampsia: effects of magnesium sulfate. Magnes Res 22(1):44–49PubMed Ariza AC, Bobadilla N, Diaz L, Avila E, Larrea F, Halhali A (2009) Placental gene expression of calcitonin gene related peptide and nitric oxide synthases in preeclampsia: effects of magnesium sulfate. Magnes Res 22(1):44–49PubMed
33.
Zurück zum Zitat Halhali A, Wimalawansa SJ, Berentsen V, Avila E, Thota CS, Larrea F (2001) Calcitonin gene and parathyroid hormone related peptides in preeclampsia: effects of magnesium sulfate. Obstet Gynecol 97(6):893–897PubMedCrossRef Halhali A, Wimalawansa SJ, Berentsen V, Avila E, Thota CS, Larrea F (2001) Calcitonin gene and parathyroid hormone related peptides in preeclampsia: effects of magnesium sulfate. Obstet Gynecol 97(6):893–897PubMedCrossRef
34.
Zurück zum Zitat Gangula PR, Zhao H, Wimalawansa SJ, Supowit SC, DiPette DJ, Yallampalli C (2001) Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol Reprod 64(6):1776–1783PubMedCrossRef Gangula PR, Zhao H, Wimalawansa SJ, Supowit SC, DiPette DJ, Yallampalli C (2001) Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol Reprod 64(6):1776–1783PubMedCrossRef
35.
Zurück zum Zitat Stevenson JC, Macdonald DW, Warren RC, Booker MW, Whitehead MI (1986) Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J 293(6558):1329–1330CrossRef Stevenson JC, Macdonald DW, Warren RC, Booker MW, Whitehead MI (1986) Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J 293(6558):1329–1330CrossRef
36.
Zurück zum Zitat Taquet H, Uzan S (1992) Plasma calcitonin gene-related peptide during gestation (Letter). Lancet 340:1170PubMedCrossRef Taquet H, Uzan S (1992) Plasma calcitonin gene-related peptide during gestation (Letter). Lancet 340:1170PubMedCrossRef
37.
Zurück zum Zitat Thota C, Gangula PR, Dong YL, Yallampalli C (2003) Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments. Biol Reprod 69(4):1432–1437PubMedCrossRef Thota C, Gangula PR, Dong YL, Yallampalli C (2003) Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments. Biol Reprod 69(4):1432–1437PubMedCrossRef
38.
Zurück zum Zitat Dong YL, Vegiraju S, Gangula PR, Kondapaka SB, Wimalawansa SJ, Yallampalli C (2002) Expression and regulation of calcitonin gene-related peptide receptor in rat placentas. Biol Reprod 67(4):1321–1326PubMed Dong YL, Vegiraju S, Gangula PR, Kondapaka SB, Wimalawansa SJ, Yallampalli C (2002) Expression and regulation of calcitonin gene-related peptide receptor in rat placentas. Biol Reprod 67(4):1321–1326PubMed
39.
Zurück zum Zitat Gallacher SJ, Fraser WD, Owens OJ et al (1994) Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 131:369–374PubMedCrossRef Gallacher SJ, Fraser WD, Owens OJ et al (1994) Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 131:369–374PubMedCrossRef
40.
Zurück zum Zitat Ardawi MS, Nasrat HA, BA’Aqueel HS (1997) Calcium regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol 137:402–409PubMedCrossRef Ardawi MS, Nasrat HA, BA’Aqueel HS (1997) Calcium regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol 137:402–409PubMedCrossRef
41.
Zurück zum Zitat Lippuner K, Zehnder HJ, Casez JP, Takkinen R, Jaeger P (1996) PTH-related protein is released into the mother’s bloodstream during location: evidence for beneficial effects on maternal calcium-phosphate metabolism. J Bone Miner Res 11(10):1394–1399PubMedCrossRef Lippuner K, Zehnder HJ, Casez JP, Takkinen R, Jaeger P (1996) PTH-related protein is released into the mother’s bloodstream during location: evidence for beneficial effects on maternal calcium-phosphate metabolism. J Bone Miner Res 11(10):1394–1399PubMedCrossRef
42.
Zurück zum Zitat Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D (1996) Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276(7):549–554PubMedCrossRef Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D (1996) Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276(7):549–554PubMedCrossRef
43.
Zurück zum Zitat Dobnig H, Kainer F, Stepan V et al (1995) Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 80:3699–3707PubMed Dobnig H, Kainer F, Stepan V et al (1995) Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 80:3699–3707PubMed
Metadaten
Titel
Calcitonin gene- and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case–control study
verfasst von
Sonali Yadav
Yogendra Singh Yadav
Madhu Mati Goel
Urmila Singh
Shankar Madhav Natu
Mahendra Pal Singh Negi
Publikationsdatum
01.11.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2014
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3303-8

Weitere Artikel der Ausgabe 5/2014

Archives of Gynecology and Obstetrics 5/2014 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.